BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 22907116)

  • 1. Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.
    Choi SR; Howell OW; Carassiti D; Magliozzi R; Gveric D; Muraro PA; Nicholas R; Roncaroli F; Reynolds R
    Brain; 2012 Oct; 135(Pt 10):2925-37. PubMed ID: 22907116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis.
    Howell OW; Reeves CA; Nicholas R; Carassiti D; Radotra B; Gentleman SM; Serafini B; Aloisi F; Roncaroli F; Magliozzi R; Reynolds R
    Brain; 2011 Sep; 134(Pt 9):2755-71. PubMed ID: 21840891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis.
    Reali C; Magliozzi R; Roncaroli F; Nicholas R; Howell OW; Reynolds R
    Brain Pathol; 2020 Jul; 30(4):779-793. PubMed ID: 32243032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.
    Magliozzi R; Howell O; Vora A; Serafini B; Nicholas R; Puopolo M; Reynolds R; Aloisi F
    Brain; 2007 Apr; 130(Pt 4):1089-104. PubMed ID: 17438020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis.
    Magliozzi R; Howell OW; Durrenberger P; Aricò E; James R; Cruciani C; Reeves C; Roncaroli F; Nicholas R; Reynolds R
    J Neuroinflammation; 2019 Dec; 16(1):259. PubMed ID: 31810488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration.
    van Olst L; Rodriguez-Mogeda C; Picon C; Kiljan S; James RE; Kamermans A; van der Pol SMA; Knoop L; Michailidou I; Drost E; Franssen M; Schenk GJ; Geurts JJG; Amor S; Mazarakis ND; van Horssen J; de Vries HE; Reynolds R; Witte ME
    Acta Neuropathol; 2021 Jun; 141(6):881-899. PubMed ID: 33779783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis.
    Magliozzi R; Howell OW; Reeves C; Roncaroli F; Nicholas R; Serafini B; Aloisi F; Reynolds R
    Ann Neurol; 2010 Oct; 68(4):477-93. PubMed ID: 20976767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis.
    Kooi EJ; Geurts JJ; van Horssen J; Bø L; van der Valk P
    J Neuropathol Exp Neurol; 2009 Sep; 68(9):1021-8. PubMed ID: 19680141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive grey matter pathology in the cerebellum in multiple sclerosis is linked to inflammation in the subarachnoid space.
    Howell OW; Schulz-Trieglaff EK; Carassiti D; Gentleman SM; Nicholas R; Roncaroli F; Reynolds R
    Neuropathol Appl Neurobiol; 2015 Oct; 41(6):798-813. PubMed ID: 25421634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration.
    James Bates RE; Browne E; Schalks R; Jacobs H; Tan L; Parekh P; Magliozzi R; Calabrese M; Mazarakis ND; Reynolds R
    Brain; 2022 Dec; 145(12):4287-4307. PubMed ID: 35776111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningeal inflammation and cortical demyelination in acute multiple sclerosis.
    Bevan RJ; Evans R; Griffiths L; Watkins LM; Rees MI; Magliozzi R; Allen I; McDonnell G; Kee R; Naughton M; Fitzgerald DC; Reynolds R; Neal JW; Howell OW
    Ann Neurol; 2018 Dec; 84(6):829-842. PubMed ID: 30362156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningeal B Cell Clusters Correlate with Submeningeal Pathology in a Natural Model of Multiple Sclerosis.
    Church ME; Ceja G; McGeehan M; Miller MC; Farias P; Sánchez MD; Swain GP; Assenmacher CA; Stopa EG; Vite CH; Bar-Or A; Alvarez JI
    J Immunol; 2021 Jul; 207(1):44-54. PubMed ID: 34162727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of the ubiquitin-editing enzyme A20 in the brain lesions of Multiple Sclerosis patients: moving from systemic to central nervous system inflammation.
    Perga S; Montarolo F; Martire S; Bonaldo B; Bono G; Bertolo J; Magliozzi R; Bertolotto A
    Brain Pathol; 2021 Mar; 31(2):283-296. PubMed ID: 33051914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuron-specific activation of necroptosis signaling in multiple sclerosis cortical grey matter.
    Picon C; Jayaraman A; James R; Beck C; Gallego P; Witte ME; van Horssen J; Mazarakis ND; Reynolds R
    Acta Neuropathol; 2021 Apr; 141(4):585-604. PubMed ID: 33569629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats.
    Gardner C; Magliozzi R; Durrenberger PF; Howell OW; Rundle J; Reynolds R
    Brain; 2013 Dec; 136(Pt 12):3596-608. PubMed ID: 24176976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive subpial cortical demyelination is specific to multiple sclerosis.
    Junker A; Wozniak J; Voigt D; Scheidt U; Antel J; Wegner C; Brück W; Stadelmann C
    Brain Pathol; 2020 May; 30(3):641-652. PubMed ID: 31916298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectopic lymphoid follicles in progressive multiple sclerosis: From patients to animal models.
    Zhan J; Kipp M; Han W; Kaddatz H
    Immunology; 2021 Nov; 164(3):450-466. PubMed ID: 34293193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Ependymal-in" Gradient of Thalamic Damage in Progressive Multiple Sclerosis.
    Magliozzi R; Fadda G; Brown RA; Bar-Or A; Howell OW; Hametner S; Marastoni D; Poli A; Nicholas R; Calabrese M; Monaco S; Reynolds R
    Ann Neurol; 2022 Oct; 92(4):670-685. PubMed ID: 35748636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis.
    Magliozzi R; Howell OW; Calabrese M; Reynolds R
    Nat Rev Neurol; 2023 Aug; 19(8):461-476. PubMed ID: 37400550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell enrichment and Epstein-Barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis.
    Magliozzi R; Serafini B; Rosicarelli B; Chiappetta G; Veroni C; Reynolds R; Aloisi F
    J Neuropathol Exp Neurol; 2013 Jan; 72(1):29-41. PubMed ID: 23242282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.